Acer Therapeutics Inc.
Hedge Funds Holdings
Last updated:
Acer Therapeutics Inc.‘s stocks are currently a part of 14 hedge funds’ portfolios, which represents 9.95% of the total amount of its stocks outstanding. This makes up a total of 1.41M shares of Acer Therapeutics Inc.. Compared to the previous quarter, the number fell by -3.40% or -49.99K shares fewer. As for the holding position changes, 21.43% (3) of current hedge fund investors increased the number of shares held, 42.86% (6) of current holders sold a part of the shares held, and 35.71% (5) closed the holdings completely. 2 hedge funds are new holders of Acer Therapeutics Inc. stock in Q1 2022, it is 14.29% of total holders.
Hedge funds holding Acer Therapeutics (Q3 2017 – Q1 2022)
| Q3 2017 | 2 |
|---|---|
| Q4 2017 | 12 |
| Q1 2018 | 15 |
| Q2 2018 | 15 |
| Q3 2018 | 29 |
| Q4 2018 | 27 |
| Q1 2019 | 33 |
| Q2 2019 | 34 |
| Q3 2019 | 37 |
| Q4 2019 | 38 |
| Q1 2020 | 34 |
| Q2 2020 | 28 |
| Q3 2020 | 20 |
| Q4 2020 | 26 |
| Q1 2021 | 26 |
| Q2 2021 | 25 |
| Q3 2021 | 21 |
| Q4 2021 | 17 |
| Q1 2022 | 14 |
Hedge funds changes in Acer Therapeutics positions (Q3 2017 – Q1 2022)
| Q3 2017 | 2 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q4 2017 | 11 | 0 | 0 | 1 | 0 |
| Q1 2018 | 7 | 3 | 3 | 4 | -2 |
| Q2 2018 | 3 | 3 | 3 | 3 | 3 |
| Q3 2018 | 17 | 8 | 0 | 3 | 1 |
| Q4 2018 | 6 | 10 | 7 | 7 | -3 |
| Q1 2019 | 12 | 10 | 3 | 6 | 2 |
| Q2 2019 | 18 | 10 | 5 | 17 | -16 |
| Q3 2019 | 11 | 13 | 9 | 8 | -4 |
| Q4 2019 | 5 | 13 | 13 | 4 | 3 |
| Q1 2020 | 1 | 12 | 15 | 5 | 1 |
| Q2 2020 | 8 | 4 | 14 | 14 | -12 |
| Q3 2020 | 2 | 3 | 9 | 10 | -4 |
| Q4 2020 | 9 | 1 | 8 | 3 | 5 |
| Q1 2021 | 6 | 6 | 7 | 6 | 1 |
| Q2 2021 | 3 | 5 | 9 | 4 | 4 |
| Q3 2021 | 1 | 4 | 6 | 5 | 5 |
| Q4 2021 | 5 | 4 | 2 | 10 | -4 |
| Q1 2022 | 2 | 3 | 6 | 5 | -2 |
Hedge funds changes in Acer Therapeutics stock options (Q3 2017 – Q1 2022)
| Q3 2017 | 0 | 0 |
|---|---|---|
| Q4 2017 | 0 | 0 |
| Q1 2018 | 0 | 0 |
| Q2 2018 | 0 | 0 |
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 13,000 |
| Q1 2021 | 150,000 | 162,000 |
| Q2 2021 | 38,000 | 116,000 |
| Q3 2021 | 5,000 | 41,000 |
| Q4 2021 | 5,000 | 12,000 |
| Q1 2022 | 8,000 | 6,000 |